pAAV-GFP Control Plasmid

pAAV-GFP Control Plasmid
Email To BuyerPrint this PageCopy Link

Please contact your distributor for pricing.

pAAV-GFP Control Vector
Catalog Number
10 µg
Manual/Data Sheet Download
SDS Download
Map Download
Sequence Download
Product Details

Use this control vector to co-transfect along with AAV packaging vectors to produce a recombinant AAV control.

Recent Product Citations
  1. Yang Zhou, J. et al. (2020). Initial Steps for the Development of a Phage-Mediated Gene Replacement Therapy Using CRISPR-Cas9 Technology. J Clin Med. 9(5):E1498. doi: 10.3390/jcm9051498.
  2. Shin, S.M. et al. (2020). Sigma-1 receptor activity in primary sensory neurons is a critical driver of neuropathic pain. Gene Ther. doi: 10.1038/s41434-020-0157-5.
  3. Wei, Y. et al. (2020). MRG15 orchestrates rhythmic epigenomic remodelling and controls hepatic lipid metabolism. Nat Metab. doi: 10.1038/s42255-020-0203-z.
  4. Zhu, J. et al. (2020). Preparation of a Bacteriophage T4-based Prokaryotic-eukaryotic Hybrid Viral Vector for Delivery of Large Cargos of Genes and Proteins into Human Cells. Bio-protocol. 10(07): e3573. doi: 10.21769/BioProtoc.3573.
  5. Wei, P. et al. (2019). Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis. Cell Death Dis. 10(9):670. doi: 10.1038/s41419-019-1873-x.
  6. Yu, H. et al. (2019). AAV-encoded CaV2.2 peptide aptamer CBD3A6K for primary sensory neuron-targeted treatment of established neuropathic pain. Gene Ther. doi: 10.1038/s41434-019-0082-7.
  7. Zhao, Y. et al. (2019). Gain-of-Function Mutations of SLC16A11 Contribute to the Pathogenesis of Type 2 Diabetes. Cell Rep. 26(4):884-892.e4. doi: 10.1016/j.celrep.2018.12.100.
  8. Aponte-Ubillus, J.J. et al. (2019). A rAAV2-producing yeast screening model to identify host proteins enhancing rAAV DNA replication and vector yield. Biotechnol Prog. 35(1):e2725. doi: 10.1002/btpr.2725.
  9. Canny, M.D. et al. (2018). Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency. Nat Biotechnol. 36(1):95-102. doi: 10.1038/nbt.4021.
  10. Rivat, C. et al. (2018). Inhibition of neuronal FLT3 receptor tyrosine kinase alleviates peripheral neuropathic pain in mice. Nat Commun. 9(1):1042. doi: 10.1038/s41467-018-03496-2.
  11. Xiang, H. et al. (2017). Primary sensory neuron-specific interference of TRPV1 signaling by adeno-associated virus-encoded TRPV1 peptide aptamer attenuates neuropathic pain. Mol. Pain. 13: 1744806917717040.
  12. Eyquem, J. et al. (2017). Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection. Nature. 543(7643):113-117. doi: 10.1038/nature21405.